About Our Company

At Rejuvenate Bio, we are developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies. We launched out of George Church's lab at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University.

 

Leadership Team

Screen Shot 2021-08-09 at 6.56.27 AM.png

George Church, Ph.D.

Co-Founder and SAB

Screen Shot 2021-08-09 at 6.56.40 AM.png

Daniel Oliver, MBA

CEO, Co-Founder

Screen Shot 2021-08-09 at 6.56.34 AM.png

Noah Davidsohn, Ph.D.

CSO, Co-Founder

David Zhu, MBA

Investor, Board Member

Deborah Ascheim, M.D.

Chief Medical Officer

 

Investors

 

Careers at Rejuvenate Bio

Join our accomplished team of scientists in engaging research and product development